Alpha2‐adrenergic agonist vs methadone
Adverse effects (drop‐outs due to adverse effects4) · People undergoing managed opioid withdrawal
Alpha2‐adrenergic agonist showed no clear difference in drop‐out due to adverse effects compared with methadone (low certainty).
1 finding from 1 review
- Alpha₂‐adrenergic agonists for the management of opioid withdrawal 2016 · Cochrane Headline outcomes onlyRR 3.62 [0.77, 16.94]4 studies · 153 participantsLow